Aberrant markers expression in T- and B-lymphoid and myeloid leukemia cells of different differentiation stages

Neoplasma

Volumn 46, Issue 5, 1999, Pages 277-282

  Babusikova O ^a   Konikova E ^a   Kusenda, J ^a   Koubek, K ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Acute T cell; Atypical aberrant immunonophenotypes; B cell lymphoblastic and myeloid leukemia; Degree of leukemia cell maturation

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; ARTICLE; B CELL LEUKEMIA; CELL MATURATION; CHILD; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA; LEUKEMIA CELL; MAJOR CLINICAL STUDY; PHENOTYPE; T CELL LEUKEMIA;

EID: 0345634201     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BABUŠÍKOVÁ, O., MESÁROŠOVÁ, A., KONÍKOVÁ, E., KUSENDA, J., GLASOV́, M., KLOBUŠICKÁ, M.: Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease. Neoplasma, 40, 1993, 275-281.
2. BABUŠÍKOVÁ, O., GLASOVÁ, M., KUSENDA, J., KONÍKOVÁ E., MESÁROŠOVÁ, A.: Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease. Neoplasma, 41, 1994, 305-313.
3. BABUŠÍKOVÁ, O., GLASOVÁ, M., KONÍKOVÁ, E., KUSENDA, J.: Leukemia-associated phenotypes: Their characteristics and incidence in acute leukemia. Neoplasma, 43, 1996, 367-372.
4. BABUŠÍKOVÁ, O., GLASOVÁ, M., KONÍKOVÁ, E., KUSENDA, J., ČÁP, J., GYÁRFÁŠ, J., KOUBEK, K.: Phenotypic heterogeneity and aberrant markers expression in T-cell leukemia. Neoplasma, 45, 1998, 128-134.
5. BUCCHERI, V., SHETTY, V., YOSHIDA, N., MORILLA, R., MATUTES, E., CATOVSKY, D.: The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukemia. A comparison with light and electron microscopy cytochemistry. Br. J. Haematol., 80, 1992, 62-68.
6. CAMPANA, D., COUSTAN-SMITH, E., BEHM, F.G.: The definition of remission in acute leukemia with immunologic techniques. Bone Marrow Transplant., 8, 1991, 429-436.
7. CAMPANA, D., PUI, C.H.: Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood, 85, 1995, 1416-1419.
8. CAMPANA, D.: Applications of cytometry to study of acute leukemia: in vitro determination of drug sensitivity and detection of minimal residual disease. Cytometry, 18, 1994, 68-74.
9. CHESON, B.D., CASSILETH, P.A., HEAD, D.R., SCHIFFER, C.A., BENNETT, J.M., BLOOMFIELD, C.D., BRUNNING, R., GALE, R.T., GREVER, M.R., KEATING, M.J., SAWITSKY, A., STASS, S., WEINSTEIN, H., WOODS, W.G.: Report of the National Cancer Institute-sponsored Workshop on definitions of diagnosis and response in acute myeloid leukemia. J. Clin. Oncol., 8, 1990, 813-818.
10. GARAND, R., BÉNÉ, M.CH., THE GEIL: A new approach of acute lymphoblastic leukemia immunophenotypic classification: 1984-1994 the GEIL experience. Leuk. Lymph., Suppl. 1, 13, 1994, 1-5.
11. GLASOVÁ, M., KONÍKOVÁ, E., KUSENDA, J., BABUŠÍKOVÁ, O.: Evaluation of different fixation methods for simultaneous detection of surface, cytoplasmic markers and DNA analysis by flow cytometry in some human hematopoietic cell lines. Neoplasma, 42, 1995, 337-346.
12. GREAVES, M.F., CHAN, L.C., FURLEY, A.J.W., WATT, S.M., MOLGAARD, H.V: Lineage promiscuity in hemopoietic differentiation and leukemia. Blood, 67, 1986, 3-11.
13. GREAVES, M.F.: Differentiation-linked leukemogenesis in lymphocytes. Science, 234, 1986, 697-703.
14. GRIFFIN, J.D., MAYER, R.J., WEINSTEIN, H.J., ROSENTHAL, D.S., CORAL, F.S., BEVERIDGE, R.P., SCHLOSSMAN, S.F.: Surface marker analysis of acute myeloblastic leukemia: Identification of differentiation-associated phenotypes. Blood, 62, 1983, 557-566.
15. JANOSSY, G., COUSTAN-SMITH, E., CAMPANA, D.: The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases. Leukemia, 3, 1989, 170-181.
16. JENNINGS, C.D, FOON, K.A.: Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy. Blood, 90, 1997, 2863-2892.
17. KITA, K., MIWA, H., NAKASE, K., KAWAKANI, K., KOBAYASHI, T., SHIRAKAWA, S., TANAKA, I., OHTA, C., TSUTANI, H., OGUMA, S., KYO, T., DOHY, H., KAMADA, N., NASU, K., UCHINO, H.: Clinical importance of CD7 expression in acute myelocytic leukemia. Blood, 81, 1993, 2399-2405.
18. LARSON, R.A., WILLIAMS, S.F., LE BEAU, M.M.: Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood, 68, 1986, 1242-1249.
19. MACEDO, A., ORFAO, A., CIUDAD, J., GONZALES, M., VIDRIALES, B., LOPEZ-BERGES, M.C., MARTINEZ, A., LANDOLFI, C., CANIZO, C., SAN MIGUEL, J.F.: Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease. Leukemia, 9, 1995, 1896-1899.
20. MIZUTANI, M., MIWA, H., TAKAHASHI, T., KATOH, K., SHIKANI, M., KATAYAMA, N., SHIKU, H., KITA, K.: Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19. Int. J. Hematol., 66, 1997, 479-491.
21. PUI, C.H., BEHM, F.G., CRIST, W.M.: Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood, 82, 1993, 343-349.
22. RANY, S., POMBO DE OLIVEIRA, M.S., CATOVSKY, D.: Different expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides. Hematol. Pathol., 2, 1988, 73-78.
23. RASPADORI, D., LAURIA, F., VENTURA, M.A., RONDELLI, D., VISANI, G., DE VIVO, A., TURA, S.: Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: Analysis of 141 cases. Leuk. Res., 21, 1997, 603-607.
24. SANZ, M.A., SEMPERE, A.: Immunophenotyping of AML and MDS and detection of residual disease. Baillieres Clin. Haematol., 9, 1996, 35-55.
25. STASI,. R., TAYLOR, C.G., VENDITI, A., DEL POETA, G., ARONICA,. G., BASTIANELLI, C., SIMONE, M.D., BUCCISANO, F., COX,. M.C., BRUNO, A., PICCIONI, D., ABRUZZESE, E., SARGENT, J.M., TRIBALTO, M., AMADORI, S.: Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia. Ann. Hematol., 71, 1995, 13-27.
26. STELZER, G.T.: Flow cytometric analysis of hematological malignancy: Multiparameter detection of residual tumor cells. Clin. Immunol., 16, 1996, 137-143.
27. STORR, J., DOLAN, G., COUSTAN-SMITH, E., BARNETT, D., REILLY, J.T.: Value of monoclonal antimyeloperoxidase antibody (MPO7) for diagnosis of acute leukemia. J. Clin. Pathol., 43, 1990, 847-851.
28. VAN DER SCHOOT, C.E., DAANS, G.M., PINKSTER, J., VET, R., VON DEN BORNE, A.E.G.: Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukemia. Br. J. Haematol., 74, 1990, 173-179.
29. WIERSMA, S.R., ORTEGA, J., SOBEL, E., WEINBERG, K.I.: Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N. E. J. Med., 324, 1991, 800-808.